| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014808 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
| 01/18/2007 | US20070014803 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014788 Laminin-5 modulators and uses thereof |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014778 Endoribonuclease and uses thereof |
| 01/18/2007 | US20070014775 Inducing an immune mediated destruction of tumor cells by administering to an animal, a mixture of attenuated tumor cells, said cells comprising a plurality of cell surface glycoproteins on which an alpha Gal epitope is present; anticacinogenic agents; tissue-targeted therapy; gene therapy |
| 01/18/2007 | US20070014774 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 01/18/2007 | US20070014773 Compositions for regenerating defective or absent myocardium |
| 01/18/2007 | US20070014769 Adenovirus vectors comprising meganuclease-type endonucleases, and related systems |
| 01/18/2007 | US20070014768 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | DE10019075B4 Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker Use of CD34 or a polypeptide derived as a cell-surface markers or gene transfer |
| 01/18/2007 | CA2630087A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| 01/18/2007 | CA2614640A1 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743942A1 Recombinant virus vector for gene introduction in lymphocyte |
| 01/17/2007 | EP1743901A2 Oligonucleotides having A-DNA or B-DNA form |
| 01/17/2007 | EP1742965A2 Treatments for pancreatic cancer |
| 01/17/2007 | EP1742958A2 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/17/2007 | EP1742668A2 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 01/17/2007 | EP1742661A2 Lipid compositions and use thereof |
| 01/17/2007 | EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 01/17/2007 | EP1742643A2 Modulation of glucose-6-phosphatase translocase expression |
| 01/17/2007 | EP1742641A2 Methods and compositions for detecting and treating retinal diseases |
| 01/17/2007 | EP1504095B1 Site specific listeria integration vectors and methods for using the same |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1330516B1 Surface transfection and expression procedure |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1228232B1 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1131430B1 Mitogenic regulators |
| 01/17/2007 | CN1898390A Promoters for expression in modified vaccinia virus ankara |
| 01/17/2007 | CN1898385A Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 01/17/2007 | CN1898384A Msp-3-like family of genes |
| 01/17/2007 | CN1897977A In vivo gene therapy of parkinson's disease |
| 01/17/2007 | CN1896247A Fibroblast-like cell specific non-viral carrier, its construction and use |
| 01/17/2007 | CN1896235A Micromolecular RNA medicine for inhibiting osteopontin expression and its expression system |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1895669A Mucosa-immune composite adjuvant |
| 01/17/2007 | CN1295338C Polytheneimine transgened carrier of targeted fibroblast growth factor receptor |
| 01/17/2007 | CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/16/2007 | US7163927 Gene expression inhibition; treating cancer and autoimmune diseases |
| 01/16/2007 | US7163926 enhancing efficacy of a DNA plasmid vaccine which comprises a naked DNA containing and expressing in vivo a heterologous polynucleotide, an immunogen of equine rhinopheumonia virus, by adding to the DNA plasmid vaccine an adjuvant which is a polymer of acrylic or methacrylic acid |
| 01/16/2007 | US7163925 p16 expression constructs and their application in cancer therapy |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163820 genetic element (plasmid) of that strain responsible for enterotoxin (STa, STb) production was removed, while the toxin-negative Escherichia coli strain EC2173 (NBI/36) could retain the ability to produce its original fimbriae (F18ac) facilitating its intestinal colonization |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163806 mammalian therapeutics free from prion contamination |
| 01/16/2007 | US7163797 50 human secreted proteins |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/16/2007 | CA2401492C Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 01/16/2007 | CA2294196C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 01/16/2007 | CA2252055C Fusogenic liposomes |
| 01/16/2007 | CA2158733C Gas driven gene delivery instrument |
| 01/11/2007 | WO2007005987A2 Methods and compositions for treating diseases targeting maba1 |
| 01/11/2007 | WO2007005879A2 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 01/11/2007 | WO2007005766A1 Genomic nucleic acid sequence for cyanovirin-n and signal peptide thereof |
| 01/11/2007 | WO2007005502A2 Methods and compositions for treating diseases targeting cdcp1 |
| 01/11/2007 | WO2007004587A1 Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, malignant tumor cell suppressive viral vector, and kit using the same |
| 01/11/2007 | WO2006120455A3 Ovalbumin promoter constructs for retroviral vectors |
| 01/11/2007 | WO2006106519A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 01/11/2007 | WO2006105344A3 Methods for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 01/11/2007 | WO2006102653A3 Methods and compositions for treating insulin resistance and obesity-induced diseases |
| 01/11/2007 | WO2006100089A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 01/11/2007 | WO2006078646A3 A class of supramolecular drug molecules and methods of identification and use thereof |
| 01/11/2007 | WO2006074367A3 Method of predicting and reducing risk of metastasis of breast cancer to lung |
| 01/11/2007 | WO2006063164A3 Compositions and methods for treating neuroendocrine tumors |
| 01/11/2007 | WO2006060089A3 Novel methods for producing adenoviral vector preparations with reduced replication-competent adenovirus contamination and novel adenoviral vectors and preparations |
| 01/11/2007 | WO2003083057A3 Adipocytes and uses thereof |
| 01/11/2007 | US20070011759 Vector mediated organelle transfection |
| 01/11/2007 | US20070010657 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070010474 NF-kappaB oligonucleotide decoy molecules |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010472 Oligonucleotide compositions and their use to induce differentiation of cells |
| 01/11/2007 | US20070010471 HIV DNA vaccine |
| 01/11/2007 | US20070010470 Immunomodulatory oligonucleotides |
| 01/11/2007 | US20070010469 diagnosing colorectal cancer indicated by at least a two-fold increase in the amount of duplex formed from the patient sample as compared to the amount of duplex formed from the normal control |
| 01/11/2007 | US20070010468 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 01/11/2007 | US20070010467 Targeted double stranded rna mediated cell killing |
| 01/11/2007 | US20070010443 Monitoring and modulating HGF/HGFR activity |
| 01/11/2007 | US20070010435 Method for treating amyloid disease |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009949 Paramyxovirus-derived RNP |
| 01/11/2007 | US20070009941 Complementary DNAs |
| 01/11/2007 | US20070009938 Minimalist bZIP derivatives that bind to noncanonical gene regulatory sequences |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009921 Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances |
| 01/11/2007 | US20070009918 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 01/11/2007 | US20070009892 Method of preparing epitopes chimeric gene vaccine |
| 01/11/2007 | US20070009888 Compositions, splice variants and methods relating to breast specific genes and proteins |